DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 213 filers reported holding DENALI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $786,216 | -62.8% | 26,642 | -71.0% | 0.01% | -61.5% |
Q1 2023 | $2,115,210 | +1471.5% | 91,806 | +1796.8% | 0.01% | +1200.0% |
Q4 2022 | $134,600 | -88.6% | 4,840 | -87.4% | 0.00% | -85.7% |
Q3 2022 | $1,177,000 | -44.4% | 38,341 | -46.7% | 0.01% | -46.2% |
Q2 2022 | $2,116,000 | +306.9% | 71,904 | +344.7% | 0.01% | +225.0% |
Q1 2022 | $520,000 | +48.1% | 16,169 | +105.6% | 0.00% | +33.3% |
Q4 2021 | $351,000 | -27.6% | 7,866 | -18.1% | 0.00% | -50.0% |
Q3 2021 | $485,000 | -59.0% | 9,606 | -36.2% | 0.01% | -53.8% |
Q2 2021 | $1,182,000 | -75.3% | 15,068 | -82.0% | 0.01% | -78.7% |
Q1 2021 | $4,776,000 | +165.8% | 83,641 | +290.0% | 0.06% | +144.0% |
Q4 2020 | $1,797,000 | -42.7% | 21,449 | -75.5% | 0.02% | -45.7% |
Q3 2020 | $3,138,000 | +530.1% | 87,569 | +325.3% | 0.05% | +411.1% |
Q2 2020 | $498,000 | +21.2% | 20,590 | -12.4% | 0.01% | -18.2% |
Q1 2020 | $411,000 | -15.1% | 23,499 | +12.8% | 0.01% | -31.2% |
Q1 2019 | $484,000 | +163.0% | 20,840 | +77.0% | 0.02% | +60.0% |
Q4 2017 | $184,000 | – | 11,775 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |